Back to LCT Homepage Targeting Huntington's Disease, Stroke, Type 1 Diabetes and Haemophilia
Living Cell Technologies
LCT - Living Cell Technologies
News updates: Subscribe
Unsubscribe


June 5, 2008
LCT Expands Diabetes Clinical Trial
June 3, 2008
LCT Lists on International OTCQX
May 21, 2008
LCT interviewed by New Zealand TV program, Close Up
May 12, 2008
LCT presents encapsulation technology at conference
May 8, 2008
LCT features on Channel Ten News
May 8, 2008
LCT prepares to list on international OTCQX
 

News

Pig cell diabetes treatment two steps away
By Errol Kiong
New Zealand Herald
December 20, 2006

Experimental pig-cell transplants for diabetics are a step closer to resumption after a 10-year-ban imposed over animal-to-human
disease fears.
The New Zealand regulator MedSafe yesterday gave the Living Cell Technologies biotech company a licence to manufacture its animal cell products for humans.
The licence is the first in a three-step process towards obtaining approval for human clinical trials in New Zealand next year.

Related Link:
New Zealand Herald Article - Pig cell diabetes treatment two steps away

LCT - Living Cell Technologies
What is xenotransplantation?
The use of living animal cells, tissues or organs in human therapeutics. >more

What is DiabeCell?
DiabeCell is a porcine pancreatic cell product for the treatment of insulin-dependent diabetes. >more

What is NeurotrophinCell?
A choroid plexus (brain) cell product with the potential to treat diseases of the nervous system such as Huntington's disease and stroke. >more

What is LCT's encapsulation technology?
The living cells are covered in a seaweed-derived coating (alginate encapsulation) to form capsules which eliminate the
need for toxic immunosuppressant drugs and allow the release of beneficial factors.
>more
   
graphic design and website design - PDF Communications Ltd